Table 1. Angiographic and procedural characteristics in matched groups.
| Matched | SIERRA-75
N = 686 |
Control
N = 686 |
P | 95% CI |
| Age | 80.6 ± 4.3 | 80.8 ± 4.4 | 0.38 | −0.26% to 0.66% |
| Women | 242 (35.2%) | 233 (34%) | 0.64 | −3.83% to 6.22% |
| BMI | 27.3 ± 3.9 | 27.1 ± 3.9 | 0.34 | −0.61% to 0.21% |
| Diabetes | 300 (43.7%) | 273 (39.8%) | 0.14 | −1.32% to 9.09% |
| Diabetes insulin-treated | 61 (8.8%) | 58 (8.4%) | 0.79 | −2.59% to 3.4% |
| Hypertension | 562 (82%) | 542 (79%) | 0.16 | −1.2% to 7.2% |
| Dyslipidemia | 415 (60.5%) | 395 (57.5%) | 0.26 | −2.2% to 8.18% |
| Smoker | 41 (6%) | 48 (7%) | 0.45 | −1.6% to 3.7% |
| Previous MI | 142 (20.7%) | 146 (21.2%) | 0.82 | −3.81% to 4.81% |
| Previous stroke | 65 (9.5%) | 77 (11.2%) | 0.30 | −1.54% to 4.95% |
| Previous PCI | 137 (20%) | 127 (18.5%) | 0.48 | −2.68% to 5.67% |
| Previous CABG | 20 (2.9%) | 26 (3.8%) | 0.35 | −1.05% to 2.89% |
| Previous heart failure | 75 (11%) | 66 (9.6%) | 0.40 | −1.83% to 4.64% |
| Previous major bleeding | 41 (6%) | 45 (6.5%) | 0.70 | −2.1% to 3.1% |
| Peripheral vasc. disease | 60 (8.7%) | 61 (8.9%) | 0.89 | −2.82% to 3.23% |
| GFR < 30 mL/min | 40 (5.8%) | 39 (5.6%) | 0.87 | −2.29% to 2.7% |
| GFR 30-60 mL/min | 261 (38%) | 245 (35.7%) | 0.37 | −2.8% to 7.38% |
| Anemia | 306 (44.6%) | 278 (40.5%) | 0.12 | −1.13% to 9.3% |
| PRECISE DAPT | 30.3 ± 11.4 | 30.8 ± 12 | 0.43 | −0.74% to 1.74% |
| CHA2DS2−VASc | 4.15 ± 1.2 | 4.06 ± 1.2 | 0.16 | −0.22% to 0.037% |
| HAS BLED | 2.6 ± 0.83 | 2.53 ± 0.85 | 0.13 | −0.16% to −0.02% |
| GRACE score | 134 ± 25 | 135.5 ± 23 | 0.25 | −1.04% to 4.04% |
| LVEF, % | 53.4 ± 11.7 | 52.8 ± 11.5 | 0.30 | −1.83% to 0.63% |
| NSTEMI | 263 (38.3%) | 242 (35.3%) | 0.25 | −2.1% to 8.08% |
| STEMI | 126 (18.3%) | 134 (19.5%) | 0.57 | −2.95% to 5.34% |
| Unstable angina | 104 (15.2%) | 110 (16%) | 0.68 | −3.05% to 4.65% |
| ACS | 493 (72%) | 486 (70.8%) | 0.62 | −3.58% to 5.97% |
| Unmatched | N = 1064 | N = 730 | ||
| Age | 80.8 ± 4.2 | 80.75 ± 4.5 | 0.8 | −0.45% to 0.35% |
| Women | 389 (36.6%) | 245 (33.5%) | 0.18 | −1.4 to 7.5% |
| BMI | 27.4 ± 4 | 27.1 ± 4 | 0.12 | −0.68% to 0.08% |
| Diabetes | 462 (43.4%) | 288 (39.4%) | 0.11 | −0.65% to 8.6% |
| Diabetes insulin-treated | 106 (10%) | 60 (8.2%) | 0.2 | −0.97% to 4.4% |
| Hypertension | 885 (83.2%) | 584 (80%) | 0.08 | −0.42% to 6.9% |
| Dyslipidemia | 664 (62.4%) | 415 (56.8%) | 0.02 | 0.99% to 10.2% |
| Smoker | 71 (6.6%) | 51 (7%) | 0.7 | −1.9% to 2.9% |
| Previous MI | 213 (20%) | 153 (20.9%) | 0.6 | −0.29% to 4.7% |
| Previous stroke | 90 (8.4%) | 80 (11%) | 0.06 | −0.16% to 5.5% |
| Previous PCI | 234 (22%) | 133 (18.2%) | 0.05 | −0.004% to 7.57% |
| Previous CABG | 31 (2.9%) | 29 (4%) | 0.21 | −0.6% to 2.99% |
| Previous heart failure | 110 (10.3%) | 72 (9.8%) | 0.7 | −2.4% to 3.3% |